Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.

NCT07153146 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
142
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Protagonist Therapeutics, Inc.